Zortrax SA
0.08
PLN
+0.00
(-0.65%)
ISIN
PLCRLNS00018
Return %
Stock
S&P 500
1Y
9.29
14.20
3Y
-75.79
81.12
5Y
-97.34
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Mariusz Babula
- Full Time Employees
- 4
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Olsztyn Poland
- IPO Date
- Apr 20, 2015
- Website
- zortrax.com
- Similar Companies
- Business
- Zortrax S.A. is a Poland-based technology company that designs, develops, manufactures, and distributes comprehensive additive manufacturing solutions and integrated 3D printing ecosystems for industrial, commercial, and professional applications. Founded in 2013 and headquartered in Olsztyn, Poland, the company operates internationally across Europe, North America, and Asia, catering to diverse sectors including aerospace, automotive, engineering, healthcare, dentistry, architecture, and consumer product design. The company operates through an integrated ecosystem model comprising hardware, proprietary materials, post-processing equipment, and slicing software. Its primary hardware offerings include the M Series desktop and professional 3D printers, such as the M200 Plus, M300 Plus, and M300 Dual, which utilize Layer Plastic Deposition (LPD) technology for rapid prototyping and end-use production; the Endureal industrial-grade high-temperature 3D printer, engineered to process advanced high-performance polymers including PEEK, PAEK, PEI, and PPSU; and the Inkspire and Inkspire 2 high-precision UV LCD resin 3D printers tailored for demanding dental, medical, and jewelry manufacturing. The company complements its additive manufacturing hardware with automated post-processing devices, including the Apoller smart vapor smoothing device for automated surface finishing; the Zortrax Cleaning Station; and the Zortrax Curing Station for resin part post-curing. Additionally, Zortrax supplies a dedicated line of proprietary consumables comprising standard and engineering thermoplastic filaments, such as Z-ABS, Z-ULTRAT, Z-PETG, Z-ESD, and high-temperature polymers; specialized dental and engineering photopolymer resins; and Z-SUITE, a proprietary slicing and print farm management software platform supporting file preparation, model optimization, and fleet administration. In recent corporate and strategic developments, Zortrax has undertaken court-supervised restructuring proceedings to streamline operations, reduce real estate and overhead costs, and restructure liabilities with creditors and financial authorities. Alongside financial and operational stabilization efforts, the company has advanced strategic research and development initiatives, maintaining ongoing partnerships in high-technology domains, including research collaborations with the European Space Agency on advanced 4D printing technologies and high-performance space applications, alongside exploratory development in advanced composite materials and autonomous technology segments.